Dottorato in INNOVATION IN IMMUNO-MEDIATED AND HEMATOLOGICAL DISORDERS

email: fabrizio.conti@uniroma1.it
telefono: +39 3386215679
edificio: VII Padiglione
stanza: Direzione III Piano

Fabrizio Conti
Indirizzo:
Lavoro: Reumatologia, Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Azienda Policlinico Umberto I, Viale del Policlinico 155, 00161, Roma, Italia.
Cittadinanza Italiana
Data di nascita 26/02/1964

CNTFRZ64B26H501W
Professore ordinario di Reumatologia MED 16, Sapienza Università di Roma. Direttore della UOC di Reumatologia, AUO Policlinico UMberto I, Roma.
Il 30/12/2010, dopo espletamento di concorso pubblico, è stato nominato Professore di ruolo di II fascia, settore s/d MED/16 (Reumatologia), Facoltà di Medicina e Odontoiatria, Sapienza Università di Roma.
Dal 01/06/2001 ad oggi ricopre il ruolo di Dirigente Medico presso la UOC di Reumatologia del Dipartimento di Dipartimento di Medicina Interna e Specialità Mediche, Azienda Policlinico Umberto I, Sapienza Università di Roma (Direttore Prof. Guido Valesini).
Dal 08/08/2000 al 31/5/2001, dopo aver espletato concorso pubblico per Dirigente Medico con contratto a tempo indeterminato area Medicina Interna, ha ricoperto il ruolo di Dirigente Medico presso la Divisione di Medicina Generale dell’Ospedale di Tivoli, Asl RMG.

Membro della Società Italiana di Reumatologia.
Membro del Consiglio Direttivo della Società Italiana di Reumatologia.
Membro del gruppo di studio della Società Italiana di Reumatologia per il lupus neuropsichiatrico.

Istruzione e formazione
Dottorato di Ricerca in Immunologia Sperimentale - XIV ciclo, durata del corso quattro anni, sede amministrativa Università degli Studi Magna Graecia di Catanzaro
Specializzazione in Medicina Interna conseguita presso l’Università degli Studi di Roma “La Sapienza” con votazione 70/70 e lode.
Laurea in Medicina e Chirurgia conseguita presso l’Università degli Studi di Roma “La Sapienza” con votazione 110/110 e lode.
Sotto la guida del Prof. Guido Valesini, ha acquisito una vasta esperienza clinica e nella ricerca teorico-applicativa nel campo delle malattie reumatiche. L’attività di ricerca è stata orientata verso una maggiore comprensione dei meccanismi eziopatogenetici delle malattie autoimmuni sistemiche con particolare riguardo al lupus eritematoso sistemico e alle altre connettiviti, alla sindrome da anticorpi antifosfolipidi, oltre che alla valutazione delle terapie innovative.
Autore di oltre170 pubblicazioni scientifiche in extenso in lingua inglese riportate su www.pubmed.com.
Italiana

Dal settembre 2008 ha istituito la Lupus Clinic del Dipartimento di Dipartimento di Medicina Interna e Specialità Mediche, Azienda Policlinico Umberto I, Roma: ambulatorio speciale per la diagnosi e terapia del lupus eritematoso sistemico e della sindrome da anticorpi antifosfolipidi. Da allora ne è il responsabile.
Ottima competenza informatica.


1. Valesini G, Conti F, Priori R, Balsano F.
Gilbert’s syndrome and chronic fatigue syndrome.
Lancet 341:1162-1163; 1993.

2. R Priori, F Conti, FL Luan, C Arpino, G Valesini.
Chronic fatigue: a peculiar evolution of eosinopholia-myalgia syndrome following treatment with L-tryptophane in four Italian adolescents.
Eur J Pediatrics 153:344-346; 1994.

3. F Conti, R Priori, G De Petrillo, AC Rusconi, C Arpino, G Valesini.
Prevalence of chronic fatigue syndrome in Italian patients with persistent fatigue.
Ann Ital Med Int 9:219-222; 1994.

4. G Valesini, R Priori, F Conti.
Chronic Fatigue Syndrome: what factors trigger it off?
Clin Exp Rheumatol 12:473-476; 1994.

5. Valesini G, Priori R, Conti F.
Saddle nose in relapsing polichondritis: a problem of differential diagnosis.
N Eng J Med 333:525-526; 1995.

6. F Conti, L Magrini, R Priori, P Rotiroti, G Valesini, S Bonini.
Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome.
Allergy 51:124-127; 1996.

7. S Morelli, C Barbieri, A Sgreccia, L Ferrante, V Pittoni, F Conti, G Gualdi, E Polettini, O Carlesimo, S Calvieri.
Relationship between cutaneous and pulmonary involvement in Systemic Sclerosis.
J Rheumatol 25:85-89; 1997.

8. Priori R, Conti F, Pittoni V, Valesini G.
Relapsing polichondritis: a syndrome rather than a distinct clinical entity.
Clin Exp Rheumatol 15:334-335; 1997.

9. M Sorice, V Pittoni, A Circella, R Misasi, F Conti, A Longo, GM Pontieri, G Valesini.
Anti-prothrombin but not “pure” anticardiolipin antibodies are associated with the clinical features of the Antiphospholipid Antibodies Syndrome.
Thromb Haemost 80:713-715; 1998.

10. B Caronti, C Calderaro, C Alessandri, F Conti, R Tinghino, C Pini, G Palladini, G Valesini.
Serum anti-2-glycoprotein I antibodies from patients with antiphospholipid antibodies syndrome bind central nervous system.
J Autoimmun 11:425-429; 1998

11. R Priori, M Tomassini, L Magrini, F Conti, G Valesini.
Churg-Strauss syndrome during pregnancy after steroid withdrawal.
Lancet 352:1499-1500; 1998

12. F Conti, V Pittoni, P Sacerdote, R Priori, PL Meroni, G Valesini.
Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with Chronic Fatigue Syndrome.
Clin Exp Rheumatol 16:729-732; 1998.

13. B Caronti, C Calderaro, C Alessandri, F Conti, R Tinghino, G Palladini, G Valesini.
Beta2-glycoprotein I (β2-GPI) mRNA is expressed by several cell types involved in antiphospholipid syndrome-related tissue damage.
Clin Exp Immunol 115:214-219; 1999

14. Praticò D, Ferro D, Iuliano L, Rokach J, Conti F, Valesini G, FitzGerald GA, Violi F.
Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation.
Blood 93:3401-3407; 1999.

15. F Conti, R Priori, V Pittoni, P Pivetti-Pezzi, G Valesini.
Antiphospholipid antibody syndrome in Behçet’s disease.
Lancet 354:73; 1999.

16. Arpino C, Carrieri MP, Valesini G, Pizzigallo E, Rovere P, Tirelli U, Conti F, Dialmi P, Barberio A, Rusconi N, Bosco O, Lazzarin A, Saracco A, Moro ML, Vlahov D.
Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions.
Ann Ist Super Sanità 35:435-441; 1999.

17. R Priori, F Conti, V Pittoni, T Garofalo, M Sorice, G Valesini.
Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behçet’s disease?
Thromb Haemost 83:173-174; 2000.

18. U Ramenghi, S Bonissoni, G Migliaretti, S De Franco, F Bottarel, D Buonfiglio, C Gambaruto, R Priori, F Conti, I Dianzani, G Valesini, F Merletti, U Dianzani.
Deficiency of the FAS apoptosis pathway without gene mutations is a familial trait predisposing to the development of autoimmune disease and cancer.
Blood 95:3176-3182; 2000.

19. F Conti, R Priori, C Alessandri, FR Spinelli, E Medda, G Valesini.
Safety profile and causes of withdrawal due to adverse events in Systemic Lupus Erythematosus patients treated long-term with Cyclosporine A.
Lupus 9:676-680; 2000.

20. S Morelli, AM Gurgo Di Castelmenardo, F Conti, A Sgreccia, C Alessandri, ML Bernardo, G Valesini.
Cardiac involvement in patients with Wegener’s granulomatosis.
Rheumatol Int 19:209-212; 2000.

21. F Conti, FR Spinelli, A Ossandon, G Valesini.
Selective cyclooxygenase-2 inhibition: biological and clinical effects.
Isr Med Assoc J 2:841-847; 2000.

22. RS Shacterle, F Conti, L Magrini, AL Komaroff, G Valesini.
Increased Eosinophil Protein X levels in Chronic Fatigue Syndrome.
Journal of Chronic Fatigue Syndrome 9:21-30; 2001.

23. Pittoni V, Bombardieri M, Spinelli FR, Scrivo R, Alessandri C, Conti F, Spadaro A, Valesini G.
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13.
Ann Rheum Dis 61:723-725; 2002.

24. Ferro D, Iuliano L, Violi F, Valesini G, Conti F.
Antioxidant treatment decreases the titer of circulating anticardiolipin antibodies: comment on the article by Sambo et al.
Arthritis Rheum 46:3110-3112; 2002.

25. Conti F, Sorice M, Circella A, Alessandri C, Pittoni V, Caronti B, Calderaro C, Griggi T, Misasi R, Valesini G.
Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression.
Clin Exp Immunol 132:509-516; 2003.

26. Alessandri C, Bombardieri M, Scrivo R, Viganego F, Conti F, De Luca N, Riccieri V, Valesini G.
Anti-carbonic anhydrase II antibodies in systemic sclerosis: association with lung involvement.
Autoimmunity 36:85-89; 2003.

27. Priori R, Medda E, Conti F, Cassarà EA, Danieli MG, Gerli R, Giacomelli R, Franceschini F, Manfredi A, Pietrogrande M, Stazi MA, Valesini G.
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study.
Lupus 12:735-740; 2003.

28. Magrini L, Rotiroti G, Conti F, Viganego F, Alessandri C, Picardo V, Valesini G.
Orbital myositis in a patient with primary biliary cirrhosis: successful treatment with methotrexate and corticosteroids.
Isr Med Assoc J 5:825-826; 2003.

29. Morelli S, Bernardo ML, Viganego F, Sgreccia A, De Marzio P, Conti F, Priori R, Valesini G.
Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus.
Lupus 12:805-812; 2003.

30. Ferro D, Pignatelli P, Loffredo L, Conti F, Valesini G, D'Angelo A, Violi F.
Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies.
Arthritis Rheum 50:1693-1694; 2004.

31. Alessandri C, Conti F, Valesini G.
Role of anti-glial fibrillary acidic protein antibodies in the pathogenesis of neuropsychiatric systemic lupus erythematosus should be clarified: comment on the article by Trysberg et al.
Arthritis Rheum 50:1698-1699; 2004.

32. Conti F, Alessandri C, Bompane D, Bombardieri M, Spinelli FR, Rusconi AC, Valesini G.
Autoantibody profile in systemic lupus erythematosus with psychiatric
manifestations: a role for anti-endothelial-cell antibodies.
Arthritis Res Ther 6:R366-72. Jun 17; 2004.

33. Iagnocco A, Ossandon A, Coari G, Conti F, Priori R, Alessandri C, Valesini G.
Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study.
Clin Exp Rheumatol 22:621-624; 2004.

34. Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G, Misasi R, Sorice M, Valesini G.
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Clin Exp Immunol 140:173-180; 2005.

35. F Conti, R Priori, M S Chimenti, G Coari, A Annovazzi, G Valesini, A Signore.
Successful intrarticular infliximab for resistant knee monoarthritis in a patient with spondyloarthropathy: a role for scintigraphy with 99mTc- infliximab.
Arthritis Rheum 52:1224-1226; 2005

36. Margutti P, Sorice M, Conti F, Delunardo F, Racaniello M, Alessandri C, Siracusano A, Riganò R, Profumo E, Valesini G, Ortona E.
Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations.
Arthritis Res Ther 7:R896-903; 2005

37. Conti F, Borrelli O, Anania C, Marocchi E, Romeo EF, Paganelli M, Valesini G, Cucchiara S.
Chronic intestinal inflammation and seronegative spondyloarthropathy in children.
Dig Liver Dis 37:761-767; 2005

38. Delunardo F, Conti F, Margutti P, Alessandri C, Priori R, Siracusano A, Rigano
R, Profumo E, Valesini G, Sorice M, Ortona E.
Identification and characterization of the carboxy-terminal region of Sip-1, a
novel autoantigen in Behçet's disease.
Arthritis Res Ther 8:R71; 2006.

39. Ossandon A, Bompane D, Alessandri C, Marocchi E, Conti F, Valesini G.
Leishmania in SLE mimicking an exacerbation.
Clin Exp Rheumatol 24:186-190: 2006.

40. Valesini G, Alessandri C, Celestino D, Conti F.
Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus.
Ann N Y Acad Sci 1069:118-128; 2006.

41. Chianelli M, D'Alessandria C, Conti F, Priori R, Valesini G, Annovazzi A,
Signore A.
New radiopharmaceuticals for imaging rheumatoid arthritis.
Q J Nucl Med Mol Imaging 50:217-225; 2006.

42. Alessandri C, Sorice M, Bombardieri M, Conigliaro P, Longo A, Garofalo T,
Manganelli V, Conti F, Esposti MD, Valesini G.
Antiphospholipid reactivity against cardiolipin metabolites occurring during
endothelial cell apoptosis.
Arthritis Res Ther 8:R180; 2006.

43. F Conti, S Rezai, G Valesini.
Vaccination and rheumatic diseases: is there still a dilemma?
Curr Rheumatol Review 13:79-91; 2007.

44. Priori R, Medda E, Conti F, Cassarà EA, Sabbadini MG, Antonioli CM, Gerli R,
Danieli MG, Giacomelli R, Pietrogrande M, Valesini G, Stazi MA.
Risk factors for Sjogren's syndrome: a case-control study.
Clin Exp Rheumatol 25:378-384; 2007.

45. Margutti P, Delunardo F, Colasanti T, Piro E, Profumo E, Riganò R, Siracusano A, Buttari B, Conti F, Alessandri C, Capozzi A, Sorice M, Ortona E.
Screening of endothelial expression libraries for the identification of novel
autoantigens involved in distinct autoimmune diseases characterized by
endothelial dysfunction.
Ann N Y Acad Sci 1109:178-184; 2007.

46. Sorice M, Longo A, Capozzi A, Garofalo T, Misasi R, Alessandri C, Conti F,
Buttari B, Riganò R, Ortona E, Valesini G.
Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis
factor alpha and tissue factor by signal transduction pathways involving lipid
rafts.
Arthritis Rheum 56:2687-2697; 2007.

47. Conti F, Ceccarelli F, Marocchi E, Magrini L, Spinelli FR, Spadaro A, Scrivo R,
Valesini G.
Switching tumour necrosis factor α antagonists in patients with ankylosing
spondylitis and psoriatic arthritis: an observational study over a 5-year period.
Ann Rheum Dis 66:1393-1397; 2007.

48. Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.
Infliximab treatment for ocular and extraocular manifestations of Behcet's
disease.
Jpn J Ophthalmol 51:191-196; 2007.

49. Delunardo F, Margutti P, Pontecorvo S, Colasanti T, Conti F, Rigano R, Profumo
E, Siracusano A, Capozzi A, Prencipe M, Sorice M, Francia A, Ortona E.
Screening of a microvascular endothelial cDNA library identifies rabaptin 5 as a
novel autoantigen in Alzheimer's disease.
J Neuroimmunol 192:105-112; 2007.

50. Margutti P, Matarrese P, Conti F, Colasanti T, Delunardo F, Capozzi A,
Garofalo T, Profumo E, Rigano R, Siracusano A, Alessandri C, Salvati B, Valesini
G, Malorni W, Sorice M, Ortona E.
Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and
endothelial cell apoptosis in immune-mediated vascular diseases and
atherosclerosis.
Blood 111:4559-4570; 2008.

51. Atzeni F, Bendtzen K, Bobbio-Pallavicini F, Conti F, Cutolo M, Montecucco C,
Sulli A, Valesini G, Sarzi-Puttini P.
Infections and treatment of patients with rheumatic diseases.
Clin Exp Rheumatol 26 (1 Suppl 48):S67-73; 2008.

52. F Conti, F Ceccarelli, R Priori, A Iagnocco, A Signore, G Valesini.
Intraarticular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-TNFα.
Ann Rheum Dis 67:1787-1790; 2008.

53. Conti F, Rezai S, Valesini G.
Vaccination and autoimmune rheumatic diseases.
Autoimmun Rev 8:124-128; 2008.

54. A Ossandon, A Iagnocco, C. Alessandri, R Priori, F Conti, G Valesini.
Clin Ultrasonographic depiction of knee joint alterations in systemic lupus erythematosus.
Clin Exp Rheumatol 27:329-32; 2009.

55. C Alessandri, F Conti, P Conigliaro, R Mancini, L Massaro, G Valesini.
Seronegative autoimmune disease.
Ann NY Acad Sci 1173:52-9; 2009.

56. Conti F, Scrivo R, Spinelli FR, Truglia S, Magrini L, Di Franco M, Ceccarelli F,
Valesini G.
Outcome in patients with rheumatoid arthritis switching TNF-alpha antagonists: a
single center, observational study over an 8-year period.
Clin Exp Rheumatol 27:540-1; 2009.

57. Scrivo R, Conti F, Spinelli FR, Truglia S, Magrini L, Di Franco M, Ceccarelli F,
Valesini G.
Switching between TNFalpha antagonists in rheumatoid arthritis: personal
experience and review of the literature.
Reumatismo 61:107-17; 2009.

58. Malviya G, Conti F, Chianelli M, Scopinaro F, Dierckx RA, Signore A.
Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies:
new imaging strategies to guide molecular therapies
Eur J Nucl Med Mol Imaging 37:386-398; 2010.

59. Profumo E, Buttari B, Alessandri C, Conti F, Capoano R, Valesini G, Salvati B,
Riganò R.
Beta2-glycoprotein I is a target of T cell reactivity in patients with advanced carotid atherosclerotic plaques.
Int J Immunopathol Pharmacol 23:73-80; 2010.

60. Conti F, Ceccarelli F, Perricone C, Massaro L, Spinelli FR, Valesini G.
Low incidence of flare and persistent active disease in a cohort of Italian patients with systemic lupus erythematosus: comment on the article by Nikpour et al. Arthritis Care Res 62:899–900; 2010.

61. Ortona E, Capozzi A, Colasanti T, Conti F, Alessandri C, Longo A, Garofalo T,
Margutti P, Misasi R, Khamashta MA, Hughes GR, Valesini G, Sorice M.
Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid
syndrome.
Blood 116:2960-7; 2010.

62. MA Khamashta, GRV Hughes, E Ortona, A Capozzi, T Colasanti, F Conti, C Alessandri, A Longo, T Garofalo, P Margutti, R Misasi, G Valesini, M Sorice.
Anti-vimentin/cardiolipin antibodies in “seronegative” Antiphospholipid syndrome
Blood e-Letters (17 September 2010).

63. Conti F, Perricone C, Ceccarelli F, Valesini G.
Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coin.
Autoimmun Rev 9:716-20; 2010.

64. Valesini G, Conti F.
The Persistent Challenge of Lupus Nephritis.
Clin Rev Allergy Immunol 40:135-7; 2011.

65. Conti F, Spinelli FR, Alessandri C, Valesini G.
Toll-like Receptors and Lupus Nephritis.
Clin Rev Allergy Immunol 40:192-8; 2011.

66. Conti F, Ceccarelli F, Perricone C, Alessandri C, Conti V, Massaro L, Truglia S, Spinelli F R, Spadaro A, Valesini G.
Rituximab infusion-related adverse event rates are lower in patients with
systemic lupus erythematosus than in those with rheumatoid arthritis.
Rheumatology (Oxford) 50:1148-52; 2011.

67. Mosca M, Govoni M, Tomietto P, Aringer M, Boumpas D, Cervera R, Conti F,
D'Cruz D, Doria A, De La Fuente D, Galeazzi M, Houssiau F, Huizinga TW, Khamashta MA, Ines L, Catia D, Couto M, Meroni P, Montecucco C, Norkuviene E, Riemekasten G, Rios V, Schneider M, Shoenfeld Y, Steup-Beekman G, Szmyrka-Kaczmarek M, Tani C, Tincani A, Tzioufas A, Voll R, Bencivelli W, Salaffi F, Bombardieri S.
The development of a simple questionnaire to screen SLE patients for the presence of neuropsychiatric (NP) symptoms in routine clinical practice.
Lupus 20:485-92; 2011.

68. Alessandri C, Conti F, Pendolino M, Mancini R, Valesini G.
New autoantigens in the antiphospholipid syndrome.
Autoimmun Rev 10:609-16; 2011.

69. Matarrese P, Colasanti T, Ascione B, Margutti P, Franconi F, Alessandri C, Conti F, Riccieri V, Rosano G, Ortona E, Malorni W.
Gender disparity in susceptibility to oxidative stress and apoptosis induced by autoantibodies specific to RLIP76 in vascular cells.
Antioxid Redox Signal 15:2825-36; 2011.

70. Caporali R, Conti F, Alivernini S, Atzeni F, Seriolo B, Cutolo M, Valesini G, Ferraccioli G, Sarzi-Puttini P, Salvarani C, Guiducci S, Zampogna G, Gremese E, Pipitone N, Scrivo R, Bugatti S, Montecucco C, Matucci-Cerinic M; Italian Society for Rheumatology.
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy.
Clin Exp Rheumatol 29 (3 Suppl 66):S7-14; 2011.

71. Cervera R, Conti F, Doria A, Iaccarino L, Valesini G.
Does seronegative antiphospholipid syndrome really exist?
Autoimmun Rev 11(8):581-4; 2012.

72. Colasanti T, Maselli A, Conti F, Sanchez M, Alessandri C, Barbati C, Vacirca D,
Tinari A, Chiarotti F, Giovannetti A, Franconi F, Valesini G, Malorni W,
Pierdominici M, Ortona E.
Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus.
Arthritis Rheum 64:778-87; 2012.

73. M Govoni, S Bombardieri, A Bortoluzzi, L Caniatti, C Casu, F Conti, S De
Vita, A Doria, I Farina, G Ferraccioli, E Gremese, E Mansutti, M Mosca, M
Padovan, M Piga, A Tincani, MR Tola, P Tomietto, M Taglietti, F Trotta, G
Valesini, M Zen, A Mathieu.
Factors and comorbidities associated with first neuropsychiatric event in
systemic lupus erythematosus: does a risk profile exist? A large multicentre
retrospective cross-sectional study on 959 Italian patients.
Rheumatology (Oxford) 51:157-68; 2012.

74. Conti F, Alessandri C, Sorice M, Capozzi A, Longo A, Garofalo T, Misasi R, Bompane D, Hughes GRV, Khamashta MA, Valesini G.
Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome.
Clin Exp Immunol 167:429-437; 2012.

75. Conti F, Alessandri C, Perricone C, Scrivo R, Rezai S, Ceccarelli F, Spinelli FR, Ortona E, Marianetti M, Mina C, Valesini G.
Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.
PLoS ONE 7 e33824; 2012.

76. Conti F, Malviya G, Ceccarelli F, Priori R, Iagnocco A, Valesini G, Signore A.
Role of scintigraphy with (99m)Tc-infliximab in predicting the response of
intraarticular infliximab treatment in patients with refractory monoarthritis.
Eur J Nucl Med Mol Imaging 39:1339-47; 2012.

77. De Angelis F, Di Rocco A, Minotti C, Valesini G, Cartoni C, Riminucci M, Conti F,
Finolezzi E, Armiento D, Grammatico S, Massaro L, Fama A, Colafigli G, Viccarone C, Foà R, Martelli M.
Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular
relapse of rheumatoid arthritis in a patient treated with etanercept. A case
report and literature review.
Leuk Res 36:e199-201; 2012.

78. Conti F, Ceccarelli F, Perricone C, Miranda F, Truglia S, Massaro L, Pacucci V A, Conti V, Bartosiewicz I, Spinelli F R, Alessandri C, Valesini G.
Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study.
PLoS ONE 7:e45934; 2012.

79. Alessandri C, Barbati C, Vacirca D, Piscopo P, Confaloni A, Sanchez M, Maselli A, Colasanti T, Conti F, Truglia S, Perl A, Valesini G, Malorni W, Ortona E,
Pierdominici M.
T lymphocytes from patients with systemic lupus erythematosus are resistant to
induction of autophagy.
FASEB J 26:4722-32; 2012.

80. Colasanti T, Alessandri C, Capozzi A, Sorice M, Delunardo F, Longo A,
Pierdominici M, Conti F, Truglia S, Siracusano A, Valesini G, Ortona E, Margutti
P.
Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with
TLR4 inducing a pro-inflammatory phenotype in endothelial cells and monocytes.
Blood 120:3360-70; 2012.

81. Iannuccelli C, Spinelli FR, Guzzo MP, Priori R, Conti F, Ceccarelli F, Pietropaolo M, Olivieri M, Minniti A, Alessandri C, Gattamelata A, Valesini G, Di Franco M.
Fatigue and widespread pain in Systemic Lupus Erythematosus and Sjogren's Syndrome: symptoms of the inflammatory disease or associated Fibromyalgia?
Clin Exp Rheumatol 2012; 30 (Suppl. 74): S117-S121.

82. Perricone C, Ciccacci C, Ceccarelli F, Di Fusco D, Spinelli FR, Cipriano E,
Novelli G, Valesini G, Conti F, Borgiani P.
TRAF3IP2 gene and systemic lupus erythematosus: association with disease
susceptibility and pericarditis development.
Immunogenetics 65:703-9; 2013.

83. F Conti, F Ceccarelli, L Massaro, V A Pacucci, F Miranda, S Truglia, E Cipriano, F Martinelli, I Leccese, F R Spinelli, C Alessandri, C Perricone, G Valesini.
Evaluation of the Patient Acceptable Symptom State (PASS) in Italian
Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices.
PLoS ONE 8:e73517; 2013.

84. Conti F, Ceccarelli F, Massaro L, Cipriano E, Di Franco M, Alessandri C, Spinelli
FR, Scrivo R, Valesini G.
Biological therapies in rheumatic diseases.
Clin Ter 164:e413-28; 2013.

85. Iagnocco A, Ceccarelli F, Rizzo C, Truglia S, Massaro L, Spinelli F R, Vavala C, Valesini G, Conti F.
Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus.
Rheumatology (Oxford) 53:465-72; 2014. First published online: November 14, 2013.

86. Conti F, Spinelli FR, Alessandri C, Pacelli M, Ceccarelli F, Marocchi E, Montali
A, Capozzi A, Buttari B, Profumo E, Sorice M, Arca M, Valesini G, Riganò R. Subclinical Atherosclerosis in Systemic Lupus Erythematosus and Antiphospholipid Syndrome: Focus on β2GPI-Specific T Cell Response.
Arterioscler Thromb Vasc Biol 34:661-8; 2014.

87. Conti F, Alessandri C, Spinelli F R, Capozzi A, Martinelli F, Recalchi S, Misasi R, Valesini G, Sorice M.
TLC immunostaining for the detection of “anti-phospholipid antibodies”.
Methods Mol Biol 1134:95-101; 2014.

88. Segni M, Pucarelli I, Truglia S, Turriziani I, Serafinelli C, Conti F.
High prevalence of antinuclear antibodies in children with thyroid autoimmunity.
Journal of Immunology Research 2014: Article ID 150239, 6 pages; 2014. doi:10.1155/2014/150239.

89. Conti F, Perricone C, Reboldi G, Gawlicki M, Bartosiewicz I, Pacucci V,
Massaro L, Miranda F, Truglia S, Alessandri C, Spinelli F, Teh LS, Ceccarelli F,
Valesini G.
Validation of a disease-specific health-related quality of life measure in adult
Italian patients with systemic lupus erythematosus: LupusQoL-IT.
Lupus 23:743–751; 2014 [Feb 25 Epub ahead of print].

90. Di Franco M, Gerardi MC, Lucchino B, Conti F.
Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis.
Core Evid 9:41–48; 2014.

91. Conti F, Capozzi A, Truglia S, Lococo E, Longo A, Misasi R, Alessandri C, Valesini G, Sorice M.
The mosaic of “seronegative” antiphospholipid syndrome
Journal of Immunology Research 2014; Article ID 389601, 7 pages, 2014.

92. Cervera R, Rodríguez-Pintó I, Colafrancesco S, Conti F, Valesini G, Rosário C, Agmon-Levin N, Shoenfeld Y, Ferrão C, Faria R, Vasconcelos C, Signorelli F, Espinosa G.
14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
Autoimmun Rev. 2014 Mar 20. pii: S1568-9972(14)00099-8. doi:
10.1016/j.autrev.2014.03.002. [Epub ahead of print]

93. T Colasanti, M Vomero, C Alessandri, C Barbati, A Maselli, C Camperio, F Conti, A Tinari, C Carlostella, L Tuosto, G Valesini, W Malorni, M Pierdominici, E Ortona, D Benincasa.
Role of α-synuclein in autophagy modulation of primary human T lymphocytes.
Cell Death Dis 5:e1265; 2014.

94. Di Franco M, Guzzo MP, Spinelli FR, Atzeni F, Sarzi-Puttini P, Conti F,
Iannuccelli C.
Pain and systemic lupus erythematosus.
Reumatismo 66:33-38; 2014.

95. Caporali R, Conti F, Covelli M, Govoni M, Salaffi F, Ventriglia G.
Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.
Clin Exp Rheumatol 32:471-6.; 2014. Epub 2014 Jun 23.

96. Conti F, Ceccarelli F, Gigante A, Barbano B, Perricone C, Massaro
L, Martinelli F, Spinelli FR, Giannakakis K, Valesini G, Cianci R.
Ultrasonographic Evaluation of Renal Resistive Index in Patients with Lupus
Nephritis: Correlation with Histologic Findings.
Ultrasound Med Biol 2014 Sep 11. pii: S0301-5629(14)00426-8. doi:
10.1016/j.ultrasmedbio.2014.06.016. [Epub ahead of print]

97. Bortoluzzi A, Scirè CA, Bombardieri S, Caniatti L, Conti F, De
Vita S, Doria A, Ferraccioli G, Gremese E, Mansutti E, Mathieu
A, Mosca M, Padovan M, Piga M, Tincani A, Tola MR, Tomietto
P, Valesini G, Zen M, Govoni M; on behalf of the Study Group on
Neuropsychiatric Systemic Lupus Erythematosus of the Italian Society of
Rheumatology.
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus.
Rheumatology (Oxford). 2014 Oct 21. pii: keu384. [Epub ahead of print]

98. Perricone C, Rinkevich-Shop S, Blank M, Landa-Rouben N, Alessandri C,
Conti F, Leor J, Shoenfeld Y, Valesini G.
The Autoimmune Side of Rheumatic Fever.
IMAJ 16:654–655; 2014.

99. Ceccarelli F, Perricone C, Massaro L, Pacucci VA, Cipriano E, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G, Conti F.
The role of Disease Activity Score 28 in the evaluation of articular involvement in systemic lupus erythematosus.
ScientificWorldJournal Volume 2014, Article ID 236842, 6 pages; 2014.

100. Ciccacci C, Perricone C, Ceccarelli F, Rufini S, Di Fusco D, Alessandri C,
Spinelli FR, Cipriano E, Novelli G, Valesini G, Borgiani P, Conti F.
A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene. PLoS One Nov 4;9(11):e111991; 2014.

101. Conti F, Spinelli FR, Colafrancesco S, Truglia S, Ceccarelli F, Fattapposta F, Sorice M, Capozzi A, Ferretti G, Priori R, Martinelli F, Pirone C, Alessandri C, Valesini G.
Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a
patient with systemic lupus erythematosus.
Lupus. 2014 Oct 8. pii: 0961203314554848. [Epub ahead of print]

102. Spinelli FR, Di Franco M, Metere A, Conti F, Iannuccelli C, Agati L, Valesini
G.
Decrease of asymmetric dimethyl arginine after anti-TNF therapy in patients with
rheumatoid arthritis.
Drug Dev Res. 2014 Nov;75 Suppl 1:S67-9. doi: 10.1002/ddr.21200.

103. Chimenti MS, Spinelli FR, Giunta A, Martinelli F, Saraceno R, Conti F,
Perricone R, Valesini G.
Emergence of antinuclear antibodies in psoriatic patients treated with
infliximab: personal experience and literature review.
Drug Dev Res. 2014 Nov;75 Suppl 1:S61-3. doi: 10.1002/ddr.21198.

104. Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J,
Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert
JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Cučnik S.
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from
patients with autoimmune diseases to different peptide clusters of
β2-glycoprotein I.
Immunol Res. 2014 Nov 14. [Epub ahead of print]

105. Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia
S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G.
Mycophenolate mofetil in systemic lupus erythematosus: results from a
retrospective study in a large monocentric cohort and review of the literature.
Immunol Res. 2014 Dec 3. [Epub ahead of print]

106. Perricone C, Ceccarelli F, Nesher G, Borella E, Odeh Q, Conti F, Shoenfeld Y,
Valesini G.
Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.
Immunol Res. 2014 Nov 27. [Epub ahead of print]

107. Barbati C, Alessandri C, Vomero M, Vona R, Colasanti T, Vacirca D, Camerini S, Crescenzi M, Pendolino M, Truglia S, Conti F, Garofalo T, Sorice M, Pierdominici M, Valesini G, Malorni W, Ortona E.
Autoantibodies specific to D4GDI modulate Rho GTPase mediated cytoskeleton remodeling and induce autophagy in T lymphocytes.
J Autoimmun. 58:78-89; 2015. doi: 10.1016/j.jaut.2015.01.005. Epub 2015 Jan 24.

108. Ceccarelli F, Perricone C, Massaro L, Cipriano E, Alessandri C, Spinelli FR, Valesini G, Conti F.
Assessment of disease activity in Systemic Lupus Erythematosus: Lights and
shadows.
Autoimmun Rev. 2015 14:601-8.: S1568-9972(15)00052-X. doi:
10.1016/j.autrev.2015.02.008. [Epub ahead of print].

109. Misasi R, Capozzi A, Longo A, Recalchi S, Emanuela Lococo E, Alessandri C, Conti F, Valesini G, Sorice M.
“New” antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome.
Journal of Immunology Research Volume 2015 (2015), Article ID 858542, 13 pages.

110. Perricone C, Pendolino M, Olivieri M, Conti F, Valesini G, Alessandri C. Neuropsychiatric manifestations associated with anti-endothelial cell antibodies
in systemic lupus erythematosus.
Isr Med Assoc J. 2015 Mar;17(3):171-8.

111. Conti F, Ceccarelli F, Gigante A, Perricone C, Barbano B, Massaro L, Spinelli FR, Alessandri C, Valesini G, Cianci R.
Ultrasonographic evaluation of resistive index and renal artery stenosis in
patients with anti-phospholipid syndrome: two distinct mechanisms?
Ultrasound Med Biol. 2015 Mar 20. pii: S0301-5629(15)00201-X. doi:
10.1016/j.ultrasmedbio.2015.02.009. [Epub ahead of print]

112. Mastrangelo A, Colasanti T, Barbati C, Pecani A, Sabatinelli D, Pendolino M,
Truglia S, Massaro L, Mancini R, Miranda F, Spinelli FR, Conti F, Alessandri C.
The Role of Posttranslational Protein Modifications in Rheumatological Diseases:
Focus on Rheumatoid Arthritis.
J Immunol Res. 2015;2015:712490. doi:
10.1155/2015/712490. Epub 2015 May 18.

113. Spinelli FR, Pecani A, Ceccarelli F, Alessandri C, Conti F.
Effect of Etanercept on Anti-Carbamylated Protein Antibodies in Patients with Rheumatoid Arthritis.
J Rheum Dis Treat. 1:013; 2015

114. Iaccarino L, Bartoloni E, Carli L, Ceccarelli F, Conti F, De Vita
S, Ferraccioli G, Galeazzi M, Gatto M, Gerli R, Govoni M, Gremese E, Iuliano A, Mansutti E, Moroni G, Mosca M, Nalli C, Naretto C, Padovan M, Palma , Raffiotta F, Roccatello D, Tincani A, Valesini G, Zen M, Doria A.
Efficacy and safety of off-label use of rituximab in refractory lupus: data from
The Italian Multicentre Registry.
Clin Exp Rheumatol. 33:449-56; 2015.

115. Conti F, Ceccarelli F, Perricone C, Massaro L, Marocchi E, Miranda F, Spinelli FR, Truglia S, Alessandri C, Valesini G.
Systemic Lupus Erythematosus with and without anti-dsDNA antibodies: analysis
from a large monocentric cohort.
Mediators Inflamm. 2015;2015:328078. doi: 10.1155/2015/328078. Epub 2015 May 6.

116. Foltyn Zadura A, Memon AA, Stojanovich L, Perricone C, Conti F, Valesini G,
Bogdanovic G, Hillarp A, Shoenfeld Y, Sundquist J, Leffler J, Svensson PJ, Trouw LA, Blom AM.
Factor H Autoantibodies in Patients with Antiphospholipid Syndrome
and Thrombosis.
J Rheumatol. 2015 Oct;42(10):1786-93.

117. Alessandri C, Bartosiewicz I, Pendolino M, Mancini R, Colasanti T,
Pecani A, Morello F, Mastrangelo A, Sabatinelli D, Riccieri V, Di
Franco M, Ceccarelli F, Perricone C, Conti F, Valesini G.
Anti-carbamylated protein antibodies in unaffected first-degree relatives of
rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated
protein antibodies and rheumatoid factor.
Clin Exp Rheumatol. 2015 Sep 28. [Epub ahead of print]

118. Cipriano E, Ceccarelli F, Massaro L, Spinelli FR, Alessandri C, Perricone C,
Valesini G, Conti F.
Joint involvement in patients affected by systemic lupus erythematosus:
application of the swollen to tender joint count ratio.
Reumatismo. 2015;67:62-7.

119. Spinelli FR, Ceccarelli , Alessadri C, Sili Scavalli A, Conti F, Valesini G.
Developing new evaluation methods in systemic lupus erythematosus.
International Journal of Clinical Rheumatology. 10:479-488; 2015.

120. Ceccarelli F, Perricone C, Borgiani P, Ciccacci C, Rufini S, Cipriano E, Alessandri C, Spinelli FR, Sili Scavalli A, Novelli G, Valesini G, Conti F.
Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype.
J Immunol Res. 2015;2015:745647. doi: 10.1155/2015/745647. Epub 2015 Dec 21.

121. Sorice M, Buttari B, Capozzi A, Profumo E, Facchiano F, Truglia S, Recalchi S, Alessandri C, Conti F, Misasi R, Valesini G, Riganò R.
Antibodies to age-β2 glycoprotein i in patients with antiphospholipid antibody
syndrome.
Clin Exp Immunol. 2015 Dec 24. doi: 10.1111/cei.12762. [Epub ahead of print].

122. Maselli A, Conti F, Alessandri C, Colasanti T, Barbati C, Vomero M, Ciarlo L, Patrizio M, Spinelli FR, Ortona E, Valesini G, Pierdominici M.
Low expression of estrogen receptor β in T lymphocytes and high serum levels of
anti-estrogen receptor α antibodies impact disease activity in female patients
with systemic lupus erythematosus.
Biol Sex Differ. 2016 Jan 12;7:3. doi: 10.1186/s13293-016-0057-y. eCollection
2016.

123. Vadasz Z, Goldeberg Y, Halasz K, Rosner I, Valesini G, Conti F, Perricone C, Sthoeger Z, Bezalel SR, Tzioufas AG, Levin N, Shoenfeld Y, Toubi E.
Increased soluble CD72 in systemic lupus erythematosus is in association with
disease activity and lupus nephritis.
Clin Immunol. 2016 Feb 13;164:114-118. doi: 10.1016/j.clim.2016.02.004. [Epub
ahead of print]

124. Perricone C, Versini M, Ben-Ami D, Gertel S, Watad A, Segel MJ, Ceccarelli F, Conti F, Cantarini L, Bogdanos DP, Antonelli A, Amital H, Valesini G, Shoenfeld Y.
Smoke and autoimmunity: The fire behind the disease.
Autoimmun Rev. 2016 Apr;15(4):354-74. doi: 10.1016/j.autrev.2016.01.001. Epub 2016 Jan 7.

125. Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G.
The chronic damage in systemic lupus erythematosus is driven by flares,
glucocorticoids and antiphospholipid antibodies: results from a monocentric
cohort.
Lupus. 25:719-26; 2016.

126. Gigante A, Barbano B, Di Mario F, Rosato E, Simonelli M, Rocca
AR, Conti F, Ceccarelli F, Giannakakis K, Valesini G, Cianci R.
Renal parenchymal resistance in patients with biopsy proven glomerulonephritis:
correlation with histological findings.
Int J Immunopathol Pharmacol. 2016 Apr 18. pii: 0394632016645590. [Epub ahead of print].

127. Delunardo F, Soldati D, Bellisario V, Berry A, Camerini S, Crescenzi M, Alessandri C, Conti F, Ceccarelli F, Francia A, Valesini G, Cirulli F, Siracusano A, Siracusano A, Niolu C, Alex Rubino I, Ortona E, Margutti P.
Anti-GAPDH autoantibodies as a pathogenic determinant and potential biomarker of neuropsychiatric diseases.
Arthritis Rheumatol. 2016; 68:2708-16. doi: 10.1002/art.39750. [Epub ahead of print]

128. Conti F, Ceccarelli F, Iaiani G, Perricone C, Giordano A, Amori L, Miranda F, Massaro L, Pacucci VA, Truglia S, Girelli G, Fakeri A, Taliani G, Temperoni C, Spinelli FR, Alessandri C, Valesini G.
Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus.
Arthritis Res Ther. 2016 Jul 30;18:177. doi: 10.1186/s13075-016-1079-x

129. F Conti, FR Spinelli, S Truglia, F Miranda, C Alessandri, F Ceccarelli, M Bombardieri, K Giannakakis, G Valesini.
Kidney expression of Toll Like Receptors in lupus nephritis: quantification and clinicopathological correlations.
Mediators of Inflammation Volume 2016 (2016), Article ID 7697592, 7 pages

130. Spinelli FR, Pecani A, Conti F, Mancini R, Alessandri C, Valesini G.
Post-translational modifications in rheumatoid arthritis and atherosclerosis:
Focus on citrullination and carbamylation.
J Int Med Res. 2016 Sep;44(1 suppl):81-84.

131. Ciccacci C, Perricone C, Politi C, Rufini S, Ceccarelli F, Cipriano E, Alessandri C, Latini A, Valesini G, Novelli G, Conti F, Borgiani P.
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication.
Lupus. 2016 Nov 22. pii: 0961203316679528. [Epub ahead of print]

132. Pecani A, Alessandri C, Spinelli FR, Priori R, Riccieri V, Di Franco M, Ceccarelli F, Colasanti T, Pendolino M, Mancini R, Truglia S, Barbati C, Vomero M, Sabatinelli D, Morello F, Valesini G, Conti F.
Prevalence, sensitivity and specificity of antibodies against carbamylated
proteins in a monocentric cohort of patients with rheumatoid arthritis and other
autoimmune rheumatic diseases.
Arthritis Res Ther. 2016 Nov 25;18(1):276.

133. Alessandri C, Agmon-Levin N, Conti F, Perricone C, Ortona E, Pendolino M, Capozzi A, Delunardo F, Mancini R, Truglia S, Spinelli FR, Ceccarelli F, Sorice M, Shoenfeld Y, Valesini G.
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome:
diagnostic value and relationship with clinical features.
Immunol Res. 2017 Feb 18. doi: 10.1007/s12026-017-8899-x. [Epub ahead of print]

134. Caporali R, Carletto A, Conti F, D'Angelo S, Foti R, Gremese E, Govoni M, Iannone F, Pellerito R, Sinigaglia L.
Using a modified Delphi process to establish clinical consensus for the
diagnosis, risk assessment and abatacept treatment in patients with aggressive
rheumatoid arthritis.
Clin Exp Rheumatol. 2017 Mar 3. [Epub ahead of print]

135. Ceccarelli F, Sciandrone M, Perricone C, Galvan G, Morelli F, Vicente LN, Leccese I, Massaro L, Cipriano E, Spinelli FR, Alessandri C, Valesini G, Conti F.
Prediction of chronic damage in systemic lupus erythematosus by using
machine-learning models.
PLoS One. 2017 Mar 22;12(3):e0174200. doi: 10.1371/journal.pone.0174200.
eCollection 2017.

136. Ceccarelli F, Massaro L, Perricone C, Pendolino M, Cipriano E, Truglia S, Miranda, F, Spinelli FR, Alessandri C, Valesini G, Conti F. Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and
ultrasonographic features.
Clin Exp Rheumatol. 2017 Mar 23. [Epub ahead of print]

137. Ceccarelli F, Perricone C, Cipriano E, Massaro L, Natalucci F, Capalbo G, Leccese I, Bogdanos D, Spinelli FR, Alessandri C, Valesini G, Conti F.
Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical
assessment.
Semin Arthritis Rheum. 2017 Apr 4. pii: S0049-0172(16)30257-8. doi:
10.1016/j.semarthrit.2017.03.022. [Epub ahead of print]

138. Bartalesi F, Scirè C, Requena-Méndez A, Abad MA, Buonfrate D, Caporali R, Conti F, Diaz-Gonzalez F, Fernández-Espartero C, Martinez-Fernandez C, Mascarello M, Generali E, Minisola G, Morrone A, Muñoz J, Richi P, Sakellariou G, Salas Coronas J, Spinicci M, Castelli F, Bartoloni A, Bisoffi Z, Gimenez-Sanchez F, Muñoz-Fernandez S, Matucci-Cerinic M
Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the lar.
Clin Exp Rheumatol. 2017; 35:752-765

139. Conti F, Priori R, Alessandri C, Misasi R, Capozzi A, Pendolino M, Truglia S, Frisenda S, Sorice M, Valesini G
Diagnosis of catastrophic anti-phospholipid syndrome in a patient tested negative
for conventional tests.
Clin Exp Rheumatol. 2017 Jul-Aug;35(4):678-680. Epub 2017 May 8.

140. Spinelli FR, Pecani A, Ciciarello F, Colasanti T, Di Franco M, Miranda F, Conti F, Valesini G, Alessandri C
Association between antibodies to carbamylated proteins and subclinical
atherosclerosis in rheumatoid arthritis patients.
BMC Musculoskelet Disord. 2017 May 25;18(1):214. doi: 10.1186/s12891-017-1563-8.

141 Massaro L, Ceccarelli F, Colasanti T, Pendolino M, Perricone C, Cipriano E, Natalucci F, Capalbo G, Lucchetti R, Pecani A, Vomero M, Mancini R, Spinelli FR, Alessandri C, Valesini G, Conti F.
Anti-carbamylated protein antibodies in systemic lupus erythematosus patients
with articular involvement.
Lupus. 2017 Jan 1:961203317713141. doi: 10.1177/0961203317713141. [Epub ahead of print].

142. Alessandri C, Ciccia F, Priori R, Astorri E, Guggino G, Alessandro R, Rizzo A, Conti F, Minniti A, Barbati C, Vomero M, Pendolino M, Finucci A, Ortona E, Colasanti T, Pierdominici M, Malorni W, Triolo G, Valesini G.
CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity.
Arthritis Res Ther. 2017 Jul 25;19(1):178. doi: 10.1186/s13075-017-1385-y

143. Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers
JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG
International consensus: what else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.
Autoimmun Rev. 2017 Jul 10. pii: S1568-9972(17)30183-0. doi:
10.1016/j.autrev.2017.07.012. [Epub ahead of print]

144. González-Gay MA, Montecucco C, Selva-O'Callaghan A, Trallero-Araguas E, Molberg O, Andersson H, Rojas-Serrano J, Perez-Roman DI, Bauhammer J, Fiehn C, Neri R, Barsotti S, Lorenz HM, Doria A, Ghirardello A, Iannone F, Giannini M, Franceschini F, Cavazzana I, Triantafyllias K, Benucci M, Infantino M, Manfredi M, Conti F, Schwarting A, Sebastiani G, Iuliano A, Emmi G, Silvestri E, Govoni M, Scirè CA, Furini F, Lopez-Longo FJ, Martínez-Barrio J, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Cimmino MA, Cosso C, Belotti Masserini A, Cagnotto G, Codullo V, Romano M, Paolazzi G, Pellerito R, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Batticciotto A, Bartoloni Bocci E, Gerli R, Specker C, Bravi E, Selmi C, Parisi S, Salaffi F, Meloni F, Marchioni E, Pesci A, Dei G, Confalonieri M, Tomietto P, Nuno L, Bonella F, Pipitone N, Mera-Valera A, Perez-Gomez N, Gerzeli S, Lopez-Mejias R, Matos-Costa CJ, Pereira da Silva JA, Cifrian J, Alpini C, Olivieri I, Blázquez Cañamero MÁ, Rodriguez Cambrón AB, Castañeda S, Cavagna L; AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group.
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.
Clin Exp Rheumatol. 2017 Jul 26. Epub ahead of print

145. Scrivo R, Massaro L, Barbati C, Vomero M, Ceccarelli F, Spinelli FR, Riccieri V, Spagnoli A, Alessandri C, Desideri G, Conti F, Valesini G.
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus.
PLoS One. 2017 Sep 6;12(9):e0184449. doi: 10.1371/journal.pone.0184449. eCollection 2017

146. Iaccarino L, Andreoli L, Bocci EB, Bortoluzzi A, Ceccarelli F, Conti F, De Angelis R, De Marchi G, De Vita S, Di Matteo A, Emmi G, Emmi L, Gatto M, Gerli R, Gerosa M, Govoni M, Larosa M, Meroni PL, Mosca M, Pazzola G, Reggia R, Saccon F, Salvarani C, Tani C, Zen M, Frigo AC, Tincani A, Doria A.
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.
J Autoimmun. 2017 Sep 18. pii: S0896-8411(17)30438-9. doi:

147. Arnaud L, Conti F, Massaro L, Denas G, Chasset F, Pengo V.
Primary thromboprophylaxis with low-dose aspirin and antiphospholipid antibodies: Pro's and Con's.
Autoimmun Rev. 2017 Nov;16(11):1103-1108. doi: 10.1016/j.autrev.2017.09.003. Epub 2017 Sep 11. Review.

148. Del Giudice E, Dilillo A, Tromba L, La Torre G, Blasi S, Conti F, Viola F, Cucchiara S, Duse M
Aortic, carotid intima-media thickness and flow- mediated dilation as markers of early atherosclerosis in a cohort of pediatric patients with rheumatic diseases.
Clin Rheumatol. 2017 Oct 12. doi: 10.1007/s10067-017-3705-7. [Epub ahead of print]

149. Manganelli V, Capozzi A, Truglia S, Alessandri C, Lococo E, Garofalo T, De Carolis C, Conti F, Valesini G, Sorice M, Longo A, Misasi R.
Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome.
J Immunol Res. 2017:4570715

150. Di Franco M, Lucchino B, Conti F, Valesini G, Spinelli FR.
Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis.
Mediators Inflamm. 2018:3897295

151. Conti F, Pontikaki I, D'Andrea M, Ravelli A, De Benedetti F.
Patients with juvenile idiopathic arthritis become adults: the role of transitional care.
Clin Exp Rheumatol. 2018 Apr 13. [Epub ahead of print] Review.

152. Ceccarelli F, Perricone C, Pirone C, Massaro L, Alessandri C, Mina C, Marianetti M, Spinelli FR, Valesini G, Conti F.
Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study.
PLoS One. 2018 May 3;13(5):e0196103. doi: 10.1371/journal.pone.0196103. eCollection 2018.

153. Scrivo R, Gerardi MC, Rutigliano I, Sessa P, Mipatrini D, Stricchiola GMG, Pacella E, Altobelli A, Castellani C, Alessandri C, Ceccarelli F, Di Franco M, Priori R, Riccieri V, Sili Scavalli A, Spinelli FR, La Torre G, Conti F, Valesini G.
Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study.
Clin Rheumatol. 2018 37(9):2573-2577.
154. Ciccacci C, Perricone C, Alessandri C, Latini A, Politi C, Delunardo F, Pierdominici M, Conti F, Novelli G, Ortona E, Borgiani P.
Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes.
Lupus. 27(9):1464-1469; 2018

155. Sebastiani GD, Prevete I, Iuliano A, Piga M, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Tincani A, Fredi M, Conti F, Spinelli FR, Galeazzi M, Bellisai F, Zanetti A, Carrara G, Scirè CA, Mathieu A.
Early Lupus Project: one-year follow-up of an Italian cohort of patients with
systemic lupus erythematosus of recent onset.
Lupus. 27(9):1479-1488; 2018

156. Ceccarelli F, Lucchetti R, Spinelli FR, Perricone C, Truglia S, Miranda F, Scrivo R, Alessandri C, Valesini G, Conti F.
Early response to apremilast treatment in psoriatic arthritis: a real-life ultrasonographic follow-up study.
Rheumatology (Oxford). 2018 May 29. doi: 10.1093/rheumatology/key145. [Epub ahead of print].

157. Ceccarelli F, Perricone C, Colasanti T, Massaro L, Cipriano E, Pendolino M, Natalucci F, Mancini R, Spinelli FR, Valesini G, Conti F, Alessandri C.
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus.
Arthritis Res Ther. 2018 Jun 14;20(1):126. doi: 10.1186/s13075-018-1622-z.

158. Spinelli FR, Moscarelli E, Ceccarelli F, Miranda F, Perricone C, Truglia S, Garufi C, Massaro L, Morello F, Alessandri C, Valesini G, Conti F.
Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
Lupus. 2018 Jan 1:961203318781008. doi: 10.1177/0961203318781008. [Epub ahead of print].

159. Ceccarelli F, Orrù G, Pilloni A, Bartosiewicz I, Perricone C, Martino E, Lucchetti R, Fais S, Vomero M, Olivieri M, di Franco M, Priori R, Riccieri V, Scrivo R, Shoenfeld Y, Alessandri C, Conti F, Polimeni A, Valesini G.
Porphyromonas gingivalis in the tongue biofilm is associated with the clinical outcome in rheumatoid arthritis patients.
Clin Exp Immunol. 2018 Jul 15. doi: 10.1111/cei.13184. [Epub ahead of print]

160. Favalli EG, Conti F, Atzeni F, Selmi C, D'Angelo S, Caporali R, Iannone F.
COMMENTS ON "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study".
J Am Acad Dermatol. 2018 Aug 7. pii: S0190-9622(18)32359-4. doi: 10.1016/j.jaad.2018.07.052. [Epub ahead of print]

161. Dupuis ML, Conti F, Maselli A, Pagano MT, Ruggieri A, Anticoli S, Fragale A, Gabriele L, Gagliardi MC, Sanchez M, Ceccarelli F, Alessandri C, Valesini G, Ortona E, Pierdominici M.
The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis.
Front Immunol. 2018 Aug 17;9:1903. doi: 10.3389/fimmu.2018.01903. eCollection 2018.

162. Vomero M, Barbati C, Colasanti T, Perricone C, Novelli L, Ceccarelli F, Spinelli FR, Di Franco M, Conti F, Valesini G, Alessandri C.
Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives.
Front Immunol. 2018 Jul 18;9:1577. doi: 10.3389/fimmu.2018.01577

163. Truglia S, Capozzi A, Mancuso S, Recalchi S, Spinelli FR, Perricone C, De Carolis C, Manganelli V, Riitano G, Garofalo T, Longo A, De Carolis S, Alessandri C, Misasi R, Valesini G, Sorice M, Conti F.
A Monocentric Cohort of Obstetric Seronegative Anti-Phospholipid Syndrome.
Front Immunol. 2018 Jul 20;9:1678. doi: 10.3389/fimmu.2018.01678.

164. Mackay M, Dall'Era M, Fishbein J, Kalunian K, Lesser M, Sanchez Guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Lewis EJ, Korbet SM, Conti F, Tesar V, Hruskova Z, Borba EF, Bonfa E, Chan TM, Rathi M, Gupta KL, Jha V, Hasni S, West MR, Silverman E, Solomons N, Houssiau FA, Romera Diaz J, Mejia-Vilet J, Rovin BH.
Establishing Surrogate Kidney Endpoints for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.
Arthritis Rheumatol. 2018 Sep 17. doi: 10.1002/art.40724. [Epub ahead of print]

165. Frasca L, Palazzo R, Chimenti MS, Alivernini S, Tolusso B, Bui L, Botti E, Giunta A, Bianchi L, Petricca L, Auteri SE, Spadaro F, Fonti GL, Falchi M, Evangelista A, Marinari B, Pietraforte I, Spinelli FR, Colasanti T, Alessandri C, Conti F, Gremese E, Costanzo A, Valesini G, Perricone R, Lande R.
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA.
Front Immunol. 2018 Sep 12;9:1936. doi: 10.3389/fimmu.2018.01936. eCollection 2018.

166. Ceccarelli F, Orrù G, Pilloni A, Bartosiewicz I, Perricone C, Martino E, Lucchetti R, Fais S, Vomero M, Olivieri M, di Franco M, Priori R, Riccieri V, Scrivo R, Shoenfeld Y, Alessandri C, Conti F, Polimeni A, Valesini G.
Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients.
Clin Exp Immunol. 2018 Nov;194(2):244-252.

167. Colasanti T, Fiorito S, Alessandri C, Serafino A, Andreola F, Barbati C, Morello F, Alfè M, Di Blasio G, Gargiulo V, Vomero M, Conti F, Valesini G.
Diesel exhaust particles induce autophagy and citrullination in Normal Human Bronchial Epithelial cells.
Cell Death Dis. 2018 Oct 19;9(11):1073.

168. Giacomelli R, Afeltra A, Alunno A, Bartoloni-Bocci E, Berardicurti O, Bombardieri M, Bortoluzzi A, Caporali R, Caso F, Cervera R, Chimenti MS, Cipriani P, Coloma E, Conti F, D'Angelo S, De Vita S, Di Bartolomeo S, Distler O, Doria A, Feist E, Fisher BA, Gerosa M, Gilio M, Guggino G, Liakouli V, Margiotta DPE, Meroni P, Moroncini G, Perosa F, Prete M, Priori R, Rebuffi C, Ruscitti P, Scarpa R, Shoenfeld Y, Todoerti M, Ursini F, Valesini G, Vettori S, Vitali C, Tzioufas AG.
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.
Autoimmun Rev. 2018 Nov 5. pii: S1568-9972(18)30265-9

169. Conti F, Atzeni F, Massaro L, Chiara Gerardi M, Gremese E, Passiu G, Carletto A, Malavolta N, Foti R, Ramonda R, Sarzi-Puttini P.
The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus Conference.
Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii11-vii22.

170. Ceccarelli F, Sciandrone M, Perricone C, Galvan G, Cipriano E, Galligari A, Levato T, Colasanti T, Massaro L, Natalucci F, Spinelli FR, Alessandri C, Valesini G, Conti F.
Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models.
PLoS One. 2018 Dec 4;13(12):e0207926.

171. Barbati C, Vomero M, Colasanti T, Diociaiuti M, Ceccarelli F, Ferrigno S, Finucci A, Miranda F, Novelli L, Perricone C, Spinelli FR, Truglia S, Conti F, Valesini G, Alessandri C.
TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis.
Arthritis Res Ther. 2018 Dec 7;20(1):273.

172. Capozzi A, Manganelli V, Riitano G, Recalchi S, Truglia S, Alessandri C, Longo A, Garofalo T, Misasi R, Valesini G, Conti F, Sorice M.
Tissue Factor overexpression in platelets of patients with Antiphospholipid Syndrome: induction role of anti-β2-GPI antibodies
Clin Exp Immunol. 2018 Dec 14

173. Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.
Systemic lupus erythematosus: state of the art on clinical practice guidelines.
RMD Open. 2018 Nov 27;4(2):e000793.

174. Barbati C, Vomero M, Colasanti T, Ceccarelli F, Marcosano M, Miranda F, Novelli L, Pecani A, Perricone C, Spinelli FR, Truglia S, Conti F, Valesini G, Alessandri C.
Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis.
Immunol Res. 2018 Dec 21